Published in Cancer Weekly, July 7th, 1997
"The results of this study represent a major milestone in the development of nisin, which may have the potential to be the first peptide that can be taken orally as a treatment for a serious infectious disease of the colon," said George A. Digenis, Ph.D., University of Kentucky, who collaborated on the study design.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.